Cargando…

Prognostic Value of Tumor Markers, NSE, CA125 and SCC, in Operable NSCLC Patients

The aim of this study was to investigate the prognostic value of tumor markers in operable non-small cell lung cancer (NSCLC) patients. A total of 481 NSCLC patients were enrolled in the present study. High levels of neuron-specific enolase (NSE), carbohydrate antigen 125 (CA125) and squamous cell c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Dangfan, Du, Kaiqi, Liu, Taifeng, Chen, Guojun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Molecular Diversity Preservation International (MDPI) 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3709724/ https://www.ncbi.nlm.nih.gov/pubmed/23712355 http://dx.doi.org/10.3390/ijms140611145

Ejemplares similares

Identifying the Best Marker Combination in CEA, CA125, CY211, NSE, and SCC for Lung Cancer Screening by Combining ROC Curve and Logistic Regression Analyses: Is It Feasible?
por: Yang, Qixian, et al.
Publicado: (2018)

The Combination of CA125 and NSE Is Useful for Predicting Liver Metastasis of Lung Cancer
por: Wang, Chu-Feng, et al.
Publicado: (2020)

Clinical significance and diagnostic value of serum NSE, CEA, CA19-9, CA125 and CA242 levels in colorectal cancer
por: Luo, Hai, et al.
Publicado: (2020)

Platelet count predicts prognosis in operable non-small cell lung cancer
por: YU, DANGFAN, et al.
Publicado: (2013)

Ca125 and neuron-specific enolase (NSE) as tumour markers for intra-abdominal desmoplastic small round-cell tumours.
por: Fizazi, K., et al.
Publicado: (1997)

Clinical value of combined serum CA125, NSE and 24-hour urine VMA for the prediction of recurrence in children with neuroblastoma
por: Li, Jinmin, et al.
Publicado: (2023)

Impact of HSP90α, CEA, NSE, SCC, and CYFRA21-1 on Lung Cancer Patients
por: Zhou, Wenwen, et al.
Publicado: (2021)

Retracted: Impact of HSP90α, CEA, NSE, SCC, and CYFRA21-1 on Lung Cancer Patients
por: Healthcare Engineering, Journal of
Publicado: (2023)

Methylated PTGER4 is better than CA125, CEA, Cyfra211 and NSE as a therapeutic response assessment marker in stage IV lung cancer
por: Zhang, Yunxia, et al.
Publicado: (2020)

Prognostic value of the immunohistochemistry markers CD56, TTF-1, synaptophysin, CEA, EMA and NSE in surgically resected lung carcinoid tumors
por: Georgakopoulou, Vasiliki Epameinondas, et al.
Publicado: (2022)

The serum levels of tumor marker CA19-9, CEA, CA72-4, and NSE in type 2 diabetes without malignancy and the relations to the metabolic control
por: Shang, Xiaojing, et al.
Publicado: (2017)

The Prognostic Role of Tumor Marker CA-125 in B-Cell non-Hodgkin’s Lymphoma
por: Memar, Bahram, et al.
Publicado: (2015)

Serum CA19‐9, CA‐125 and CEA as tumor markers for mucinous ovarian tumors
por: Lertkhachonsuk, Arb‐aroon, et al.
Publicado: (2020)

Prognostic value of tumor measurement parameters and SCC-Ag changes in patients with locally-advanced cervical cancer
por: Chen, Wenjuan, et al.
Publicado: (2022)

A role of the Nse4 kleisin and Nse1/Nse3 KITE subunits in the ATPase cycle of SMC5/6
por: Vondrova, Lucie, et al.
Publicado: (2020)

Ca 125 is an independent prognostic marker in resected pancreatic cancer of the head of the pancreas
por: Napoli, Niccolò, et al.
Publicado: (2023)

The prognostic value of early CA125 serum assay in epithelial ovarian carcinoma.
por: Fisken, J., et al.
Publicado: (1993)

Prediction of survival and recurrence by serum and cytosolic levels of CEA, CA125 and SCC antigens in resectable non-small-cell lung cancer.
por: Díez, M., et al.
Publicado: (1996)

The Prognostic Value of Serum Neuron Specific Enolase (NSE) and S100B Level in Patients of Acute Spinal Cord Injury
por: Du, Wenjun, et al.
Publicado: (2018)

The added value of CA125, HE4, and CA72-4 as markers for ovarian endometriosis diagnosis
por: Micu, Romeo, et al.
Publicado: (2023)

The prognostic value of pretreatment CA-125 levels and CA-125 normalization in ovarian clear cell carcinoma: a two-academic-institute study
por: Bai, Huimin, et al.
Publicado: (2016)

Prognostic Value of CEA, CA19-9, CA125, CA724, and CA242 in Serum and Ascites in Pseudomyxoma Peritonei
por: Liang, Lei, et al.
Publicado: (2021)

Diagnostic and prognostic value of CEA, CA19–9, AFP and CA125 for early gastric cancer
por: Feng, Fan, et al.
Publicado: (2017)

Neurone specific enolase (NSE) in small cell lung cancer: a tumour marker of prognostic significance?
por: Harding, M., et al.
Publicado: (1990)

Oncological markers CA-125, CA 19-9 and endometriosis
por: Fiala, Ludek, et al.
Publicado: (2018)

Analysis of the Nse3/MAGE-Binding Domain of the Nse4/EID Family Proteins
por: Guerineau, Marc, et al.
Publicado: (2012)

Nadir CA-125 has prognostic value for recurrence, but not for survival in patients with ovarian cancer
por: Piatek, Szymon, et al.
Publicado: (2021)

Relationship of tumor marker CA125 and ovarian tumor stem cells: preliminary identification
por: Zhang, Hui, et al.
Publicado: (2015)

Value of NSE and S100 Protein of Kawasaki Disease with Aseptic Meningitis in Infant
por: Wang, Jiangtao, et al.
Publicado: (2019)

Comparison of Ultrasound and Tumor Marker CA125 in Diagnosis of Adnexal Mass Malignancies
por: Behnamfar, Fariba, et al.
Publicado: (2022)

Diagnostic Value of Neuron-Specific Enolase (NSE) and Cancer Antigen 15-3 (CA 15-3) in the Diagnosis of Pleural Effusions
por: Saba, Mohammad Ali, et al.
Publicado: (2017)

Serum NSE is Early Marker of Transformed Neuroendocrine Tumor After EGFR-TKI Treatment of Lung Adenocarcinoma
por: Mao, Xiaowei, et al.
Publicado: (2022)

The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients
por: Dal Bello, M. G., et al.
Publicado: (2019)

Assessment of CA-125 First-Trimester Values as a Potential Screening Marker for Pre-Eclampsia
por: Balint, Oana, et al.
Publicado: (2023)

Predictive equation of metastasis in patients with malignant ovarian epithelial tumors with the Ca-125 marker
por: Sánchez Vega, Juan Fernando, et al.
Publicado: (2018)

Prevalence of K-RAS mutations and CA125 tumor marker in patients with ovarian carcinoma
por: Bagherlou, Nazanin, et al.
Publicado: (2020)

Prognostic significance of serum CA125 in the overall management for patients with gastrointestinal stromal tumors
por: Sui, Chao, et al.
Publicado: (2023)

Predicting value of HE4 and CA125 markers for optimal cytoreductive surgery in ovarian cancer patients
por: Saffarieh, Elham, et al.
Publicado: (2022)

Clinical analysis of four serum tumor markers in 458 patients with ovarian tumors: diagnostic value of the combined use of HE4, CA125, CA19-9, and CEA in ovarian tumors
por: Chen, Fawen, et al.
Publicado: (2018)

Prognostic Values Of Preoperative Serum CEA And CA125 Levels And Nomograms For Young Breast Cancer Patients
por: Li, Xuan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6ar63r6tc44etqu8d8522g7f2c